Skip to content

KDK KDK Change in fair value of simple agreements for future equity

Change in fair value of simple agreements for future equity at other companies

GeneDx Holdings logo
GeneDx HoldingsWGS
$2.54M+331%
The Vita Coco Company, Inc. logo
The Vita Coco Company, Inc.COCO
$2.83M+0.4%
DJT
Trump Media & Technology GroupDJT
$36.98M+3,273%
GATX logo
GATXGATX
$1.2M+140%
Vertex, Inc. logo
Vertex, Inc.VERX
$0
Evommune
 logo
Evommune EVMN
$206.46K-88.8%

Other financials

Income statement

See full
Revenue$1.8M+24.4%
Operating income-$37.9M-104%
Net income$26.5M+121%
EPS (diluted)$0.10+105%

Balance sheet

See full
Cash & equivalents$66.4M+247%
Total debt$58.4M+1,068%
Total equity-$245.9M+34.7%
Total assets$130.8M-76.5%

Cash flow

See full
Operating cash flow-$29.5M-78.7%
CapEx$5.5M+138%
Free cash flow-$35.0M-86.0%

Valuation

See full
Market cap$1.05B-18.6%
Enterprise value$1.04B
P/S252.8×

Profitability

See full
Operating margin-2,695.8%
Net margin-10,366.9%
FCF margin-278%

Returns & leverage

See full
Return on equity-21.5%
Debt / equity-0.2×
Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept kdk:FairValueAdjustmentOfSimpleAgreementsForFutureEquity.

The official record: KDK’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's change in fair value of simple agreements for future equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KDK's change in fair value of simple agreements for future equity?
KDK (KDK) reported change in fair value of simple agreements for future equity of $0 in Q1 2026.
How has KDK's change in fair value of simple agreements for future equity changed year-over-year?
KDK's change in fair value of simple agreements for future equity decreased by 100.0% year-over-year, from $108.38M to $0.
What does change in fair value of simple agreements for future equity mean?
This metric measures the change in the fair value of Simple Agreements for Future Equity (SAFE) or similar derivative instruments held on the balance sheet. It reflects the revaluation of potential future equity obligations based on changes in the underlying company valuation or market conditions.